I don’t blame them, and you shouldn’t be surprised too, after all you did unearth the US$1.9B AbbVie pay to play AAV ocular deal; consisting of a US$370m upfront entry price to collaborate/peek at the goodies… That’s roughly A$500m, more than PYC’s current market cap… I don’t think any local AU companies can even come close to a partnership deal of that size, let alone that merely being the ticket price to walk into the royal show, with a limit to only pet one farm animal specie for no more than two strokes
Ann: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, page-5
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.8¢ | 10.3¢ | $174.9K | 1.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 1219974 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 404496 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |